United States Patent and Trademark Office
Home
|
Site Index
|
Search
|
Guides
|
Contacts
|
e
Business
|
eBiz alerts
|
News
|
Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.5.0
Summary
Query:
Party Name contains all words: BRADLEY PHARMACEUTICALS, INC.
Number of results:
13
Proceeding
Filing Date
Defendant(s),
Property(ies)
Plaintiff(s),
Property(ies)
77048903
07/19/2007
Bradley Pharmaceuticals, Inc.
Mark:
PERANEX
S#:
77048903
Vestergaard Frandsen A/S
91170370
04/03/2006
Chester Valley Pharmaceuticals, Inc.
Mark:
BENZIQ
S#:
78647931
Bradley Pharmaceuticals, Inc.
Mark:
BENZASHAVE
S#:
74005857
R#:
1612636
91170305
04/03/2006
Chester Valley Pharmaceuticals, Inc.
Mark:
BENZELLE
S#:
78651054
Bradley Pharmaceuticals, Inc.
78647931
04/04/2006
Chester Valley Pharmaceuticals, Inc.
Mark:
BENZIQ
S#:
78647931
Bradley Pharmaceuticals, Inc
Mark:
BENZASHAVE
S#:
74005857
R#:
1612636
Galderma Pharmaceuticals, L.P.
Galderma Pharmaceuticals, L.P.
78494343
02/06/2006
HealthWell Ventures LLC
Mark:
NITROLEAN
S#:
78494343
Bradley Pharmaceuticals, Inc.
78466819
02/06/2006
HealthWell Ventures LLC
Mark:
NITROLENE
S#:
78466819
Bradley Pharmaceuticals, Inc.
91168156
11/18/2005
Breckenridge Pharmaceutical, Inc.
Mark:
SULFATOL
S#:
76578797
BRADLEY PHARMACEUTICALS, INC.
Mark:
SULPHO-LAC
S#:
77620453
92044863
08/26/2005
Summers Laboratories, Inc.
Mark:
KERALYT
S#:
76597448
R#:
2980683
Bradley Pharmaceuticals, Inc.
91166250
08/08/2005
HealthWell Ventures LLC
Mark:
NITROLINE
S#:
78466815
BRADLEY PHARMACEUTICALS, INC.
91164204
02/07/2005
Bradley Pharmaceuticals, Inc.
Mark:
KERALAC
S#:
78344472
Summers Laboratories, Inc
78344472
10/20/2004
Bradley Pharmaceuticals, Inc.
Mark:
KERALAC
S#:
78344472
Summers Laboratories, Inc
91161492
07/27/2004
Bradley Pharmaceuticals, Inc.
Mark:
FLORA-Q
S#:
78280045
KEMIN INDUSTRIES, INC.
74095923
N/A
BRADLEY PHARMACEUTICALS INC
Mark:
THE NATURAL SOLUTION TO VAGINAL DRYNESS
S#:
74095923
R#:
1853447
Results as of 11/18/2024 12:54 PM
Search again
|
.
HOME
|
INDEX
|
SEARCH
|
e
BUSINESS
|
CONTACT US
|
PRIVACY POLICY